Ongoing Programs

causes

Global Phase III Clinical Trial Research on Recombinant COVID-19 Vaccine (Sf9cells) in Nepal

SOLID Nepal in partnership with MSR (Beijing) Pharmaceutical Consulting Co., Ltd. is conducting a phase III clinical trial on recombinant COVID-19 vaccine (sf9cells).

Read More
logo

Attain a healthy and productive life of all individuals, especially who are poor, vulnerable, deprived and socially excluded.

SOLID Nepal Location

  • info@solidnepal.org.np
  • +(977) 01 5151855
  • www.solidnepal.org.np
  • Satdobato, Lalitpur . Bagmati . Nepal